FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld
The drug, meant to prevent Covid in people with weakened immune systems, does not work against the predominant omicron subvariant XBB.1.5.
Latest news on the coronavirus, which has killed millions during a global pandemic.
The drug, meant to prevent Covid in people with weakened immune systems, does not work against the predominant omicron subvariant XBB.1.5.